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Reactions of isatins with 5-aminopyrazole afforded the 3-(5-aminopyrazol-4-yl)-3-hydroxy-2-oxindolines in good to excellent 
yields in refluxing water. No catalysts were required in the process. The new method exhibited the characteristics including green 
process, high yields, easy operation, and mild reaction conditions. 
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Oxindole derivatives have long been the focus of consider-
able attention due to their abundance in numerous natural 
products as well as their extensive applications in biology 
and pharmacology [1–5].  A great number of compounds 
bearing oxindole moieties are reported to possess significant 
antibacterial, antiprotozoal, antiinflammatory and antitumor 
properties [6,7], and they have been widely employed as 
potential synthons for the synthesis of alkaloids, drug can-
didates and clinical pharmaceuticals [8–10]. Isatin-based 
alkylation is one of the most important strategies for the 
construction of oxindole skeleton, especially for those 
bearing a hydroxyl substituent at the C-3 position which 
also possess various bioactivities [11,12]. Compared with 
Friedel-Crafts alkylation of indole with isatin for access to 
the monosubstituted 3-indolyl-3-hydroxy oxindoles [13–15], 
related study on alkylation of aminopyrazole was rare, alt-
hough pyrazole had also been confirmed to provide privi-
leged scaffolds in lead identification/drug discovery pro-
grams as well as therapeutically useful compounds in fields 
such as cyclooxygenase inhibitors (e.g., SC-558, tepoxalin, 
and celecoxib) and cannabinoid-1 inverse agonists which 
are very promising for reducing obesity (e.g., rimonabant) 
[16]. Since the first report on the alkylation of 5-aminopyra- 
zole with isatin by molecular iodine in organic solvent [17], 
the same organic transformation has been successfully 
achieved in water by using indium catalyst [16,18]. In our 
continuous work focused on organic reactions in water, we 
found the alkylation of 5-aminopyrazole with isatin could 
be well performed in pure water without the need of any 
catalyst. The green protocol provided the products in high to 
excellent yields. Herein, we report these results. 
1  Experimental  
1.1  General information 
Melting points were uncorrected. Progresses of reactions 
were monitored by Thin Layer Chromatography (TLC). IR 
spectra were recorded on an FT-IR spectrometer using KBr 
optics. NMR spectra were recorded at room temperature in 
DMSO-d6 at 300/400 and 75/100 Hz. High resolution mass 
spectra (HRMS) were obtained on a TOF MS instrument 
with EI or ESI source.  
1.2  General procedure for the synthesis of 3 
A mixture of isatin 1 (0.5 mmol), aminopyrazole 2 (0.5 
mmol) in 3 mL water was placed in a round bottom flask. 
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The reaction was carried out at refluxing for a specific time 
(the progress was monitored by TLC). After completion of 
the reaction, the reaction mixture was cooled and filtered. 
Then the precipitate was washed with 70% ethanol for three 
times to afford the pure 3. 
1.3  Characterization data 
3-(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-5-chloro-3- 
hydroxyindolin-2-one (3aa). Light yellow solid; m.p. 
220–222°C; IR (KBr): ν 3401, 3298, 2801, 1706, 1620, 
1447 cm−1; 1H NMR (DMSO-d6, 400 MHz) δ: 10.51 (s, 1 H, 
NH), 7.57 (d, J = 7.6 Hz, 2 H, ArH), 7.47 (t, J = 7.2 Hz, 2 H, 
ArH), 7.297.32 (m, 3 H, ArH), 6.89 (d, J = 8.0 Hz, 1 H, 
ArH), 6.77 (s, 1 H, OH), 5.30 (s, 2 H, NH2), 1.50 (s, 3 H, 
CH3); 
13C NMR (DMSO-d6, 75 MHz) δ: 177.9, 146.4, 144.4, 
140.5, 138.9, 134.9, 129.3, 129.2, 126.2, 126.1, 124.9, 
122.9, 111.5, 99.1, 74.6, 12.8; HRMS (EI) calcd. for 
C18H15ClN4O2 (M) 354.0884, found 354.0890. 
3-(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-5-brom 
o-3-hydroxyindolin-2-one (3ba). Light yellow solid; m.p. 
209–211°C; IR (KBr) : ν 3498, 3402, 3296, 2795, 1707, 
1617, 1552, 1475, 1385 cm−1; 1H NMR (DMSO-d6, 400 
MHz) δ: 10.54 (s, 1 H, NH), 7.32−7.58 (m, 7 H, ArH), 6.85 
(d, J = 6.0 Hz, 1 H, ArH), 6.79 (s, 1 H, OH), 5.31 (s, 2 H, 
NH2), 151 (s, 3 H, CH3); 
13C NMR (DMSO-d6, 75 MHz) δ: 
177.8, 148.3, 144.5, 141.2, 137.5, 132.7, 129.2, 126.3, 
125.8, 124.7, 123.8, 118.1 112.7, 98.0, 74.2, 12.4; HRMS 
(EI) calcd. for C18H15BrN4O2 (M) 398.0378, found 
398.0376. 
3-(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-6-brom 
o-3-hydroxyindolin-2-one (3ca) [16]. Light yellow solid; 
m.p. 206–208°C; IR (KBr) : ν 3418, 3323, 2974, 1735, 
1554, 1528, 1478, 1387 cm1; 1H NMR (DMSO-d6, 400 
MHz) δ: 10.54 (s, 1 H, NH), 7.56 (d, J = 6.8 Hz, 2 H, ArH), 
7.47(s, 2 H, ArH), 7.30 (s, 1 H, ArH), 7.23 (s, 1 H, ArH), 
7.19 (d, J = 6.4 Hz, 1 H, ArH), 7.02 (s, 1 H, ArH), 6.75 (s, 1 
H, OH), 5.32 (s, 2 H, NH2), 1.47 (s, 3 H, CH3); HRMS(ESI) 
calcd. for C18H15BrN4O2 
+(M+H+) 398.0378, found, 398.0375. 
3-(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-3-hydro
xyindolin-2-one (3da) [16]. Light yellow solid; m.p. 
218–220°C; IR (KBr) : ν 3439, 3361, 3126, 2831, 1717, 
1521, 1473, 1387 cm−1; 1H NMR (DMSO-d6, 400 MHz) 
δ:10.30 (s, 1 H, NH), 7.54 (d, J = 7.2 Hz, 2 H, ArH), 7.43(t, 
J = 7.2 Hz, 2 H, ArH), 7.21−7.26 (m, 3 H, ArH), 6.96 (t, J = 
7.2 Hz, 1 H, ArH), 6.83 (d, J = 7.6 Hz, 1 H, ArH), 6.57 (s, 1 H, 
OH), 5.24 (s, 2 H, NH2), 1.43 (s, 3 H, CH3); HRMS (EI) 
calcd. for C18H16N4O2 (M) 320.1273, found 320.1273. 
3-(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-4-chlor 
o-3-hydroxyindolin-2-one (3ea). Light yellow solid; m.p. 
228–230°C; IR (KBr) : ν 3442, 3324, 3028, 1721, 1566, 
1524, 1382 cm1; 1H NMR (DMSO-d6, 400 MHz) δ: 10.53 
(s, 1 H, NH), 7.48 (d, J = 7.6 Hz, 2 H, ArH), 7.36 (t, J = 7.2 
Hz, 2 H, ArH), 7.15−7.18 (m, 2 H, ArH), 6.87 (d, J = 8.0 
Hz, 1 H, ArH), 6.73 (d, J = 7.6 Hz, 1 H, ArH), 6.63 (s, 1 H, 
OH), 5.22 (s, 2 H, NH2), 1.35 (s, 3 H, CH3); 
13C NMR 
(DMSO-d6, 75 MHz) δ: 177.5, 147.0, 144.1, 143.8, 139.1, 
131.2, 129.1, 128.8, 126.0, 122.7, 122.0, 108.7, 97.3, 75.2, 
12.3; HRMS (EI) calcd. for C18H15ClN4O2 (M) 354.0884, 
found 354.0884. 
3-(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-3-  
hydroxy-5-methylindolin-2-one (3fa). Light yellow solid; 
m.p. 218–220°C; IR (KBr) : ν 3489, 3400, 3298, 3051, 
2802, 1703, 1609, 1527, 1492, 1382 cm−1; 1H NMR 
(DMSO-d6, 400 MHz) δ: 10.2 (s, 1 H, NH), 7.47 (d, J = 6.8 
Hz, 2 H, ArH), 7.35 (d, J = 6.4 Hz, 2 H, ArH), 7.17−7.20 
(m, 1 H, ArH), 7.0 (s, 1 H, ArH), 6.95 (t, J = 3.2 Hz, 1 H, 
ArH), 6.64 (d, J = 7.2 Hz, 1 H, ArH), 6.50 (s, 1 H, OH), 
5.20 (s, 2 H, NH2), 2.14 (s, 3 H, CH3), 1.36 (s, 3 H, CH3); 
13C NMR (DMSO-d6, 75 MHz) δ: 178.3, 146.2, 144.8, 
139.2, 139.1, 133.0, 131.0, 129.7, 129.2, 126.1, 125.6, 
122.8, 109.6, 99.9, 74.8, 20.8, 12.8; HRMS (EI) calcd. for 
C19H18N4O2 (M) 334.1430, found 334.1436. 
3-(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-5-fluor 
o-3-hydroxyindolin-2-one (3ga). Light yellow solid; m.p. 
212–214°C; IR (KBr) : ν 3392, 3310, 2937, 2877, 1713, 
1598, 1486, 1385 cm−1; 1H NMR (DMSO-d6, 400 MHz) δ: 
10.44 (s, 1 H, NH), 7.58 (d, J = 7.6 Hz, 2 H, ArH), 7.48 (t,  
J = 7.6 Hz, 2 H, ArH), 7.31 (t, J = 7.2 Hz, 1 H, ArH), 
7.09−7.16 (m, 2 H, ArH), 6.86−6.89 (m, 1 H, ArH), 6.81 (s, 
1 H, OH), 5.34 (s, 2 H, NH2), 1.49 (s, 3 H, CH3); 
13C NMR 
(DMSO-d6, 75 MHz) δ: 178.3, 159.9, 156.8, 146.4, 144.5, 
139.0, 137.9, 134.7, 134.6, 129.2, 126.3, 122.9, 116.0, 
115.7, 112.8, 112.4, 110.9, 110.8, 99.3, 74.9, 12.8; HRMS 
(EI) calcd. for C18H15FN4O2 (M) 338.1179, found 338.1178. 
3-(5-amino-3-methyl-1-phenyl-1H-pyrazol-4-yl)-3- 
hydroxy-5-methoxyindolin-2-one (3ha). Yellow solid; m.p. 
245.5–247.8 °C; IR (KBr): ν 3444, 3344, 3166, 2844, 1720, 
1608, 1491, 1378 cm−1; 1H NMR (DMSO-d6, 400 MHz) δ: 
10.20 (s, 1H, NH), 7.58 (d, J = 7.6 Hz, 2H, ArH), 7.47 (t, J = 
7.2 Hz, 2H, ArH), 7.30 (t, J = 7.2 Hz, 1H, ArH), 6.91 (s, 1H, 
ArH), 6.84 (d, J = 8.4 Hz, 1H, ArH), 6.79 (d, J = 8.2 Hz, 1H, 
ArH), 6.63 (s, 1H, OH), 5.29 (s, 2H, NH2), 3.70 (s, 3H, 
CH3), 1.49 (s, 3H, CH3); 
13C NMR (DMSO-d6, 100 MHz) δ: 
183.5, 160.5, 151.6, 150.1, 144.4, 140.2, 139.4, 134.5, 
131.4, 128.1, 119.7, 116.9, 115.7, 105.1, 80.3, 60.9, 18.2; 
HRMS (EI) calcd. for C19H18N4O3 (M) 350.1379, found 
350.1374. 
3-(5-amino-1,3-dimethyl-1H-pyrazol-4-yl)-5-chloro-3- 
hydroxyindolin-2-one (3ab). Light yellow solid; m.p. 
188–190°C; IR (KBr) : ν 3480, 3375, 3310, 1738, 1608, 
1533, 1475, 1378 cm−1; 1H NMR (DMSO-d6, 400 MHz) δ: 
10.42 (s, 1 H, NH), 7.27 (d, J = 8.0 Hz, 1 H, ArH), 7.19 (s, 
1H, ArH), 6.84 (d, J = 8.0 Hz, 1 H, ArH), 6.56 (s, 1 H, OH), 
5.09 (s, 2 H, NH2), 3.40 (s, 3 H, CH3), 1.38 (s, 3 H, CH3); 
13C NMR (DMSO-d6, 75 MHz) δ: 178.1, 146.3, 141.4, 
140.4, 135.3, 129.1, 125.9, 124.8, 111.3, 97.8, 33.7, 12.7; 
HRMS (EI) calcd. for C13H13ClN4O2 (M) 292.0727, found 
292.0725. 
3-(5-amino-1,3-dimethyl-1H-pyrazol-4-yl)-6-bromo-3- 
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hydroxyindolin-2-one (3cb). Light yellow solid; m.p. 202– 
204°C; IR (KBr) : ν 3405, 3278, 1715, 1609, 1534, 1448 
cm−1; 1H NMR (DMSO-d6, 400 MHz) δ: 10.42 (s, 1 H, NH), 
7.14 (s, 2 H, ArH), 6.98 (s, 1 H, ArH), 6.50 (s, 1 H, OH), 
5.09 (s, 2 H, NH2), 3.41 (s, 3 H, CH3), 1.36 (s, 3 H, CH3); 
13C NMR (DMSO-d6, 75 MHz) δ: 178.3, 146.4, 143.3, 
141.6, 132.6, 126.8, 124.6, 121.8, 112.6, 97.7, 74.3, 33.7, 
12.7; HRMS (EI) calcd. for C13H13BrN4O2 (M) 336.0222, 
found 336.0224. 
3-(5-amino-1,3-dimethyl-1H-pyrazol-4-yl)-5-bromo-3-  
hydroxyindolin-2-one (3bb). Light yellow solid; m.p. 198– 
200°C; IR (KBr) : ν 3484, 3388, 3320, 3005, 1734, 1616, 
1540, 1474, 1389 cm−1; 1H NMR (DMSO-d6, 400 MHz) δ: 
10.46 (s, 1 H, NH), 7.30−7.41 (m, 2 H, ArH), 6.80-6.81 (m 
1 H, ArH), 6.57 (s, 1 H, OH), 5.1 (s, 2 H, NH2), 3.42 (s, 3 H, 
CH3), 1.39 (s, 3 H, CH3); 
13C NMR (DMSO-d6, 75 MHz) δ: 
178.0, 146.3, 141.8, 140.8, 135.7, 131.9, 127.5, 113.5, 
111.8, 97.8, 74.6, 33.7, 12.7; HRMS (EI) calcd. for 
C13H13BrN4O2 (M) 336.0222, found 336.0223. 
3-(5-amino-1,3-dimethyl-1H-pyrazol-4-yl)-3-hydroxyind
olin-2-one (3db). Light yellow solid; m.p. 194–196 °C; IR 
(KBr) : ν 3445, 3362, 2817, 1715, 1620, 1539, 1471, 1393 
cm−1; 1H NMR (DMSO-d6, 400 MHz) δ: 10.25 (s, 1 H, NH), 
7.19 (d, J = 7.2 Hz, 2 H, ArH), 6.94 (t, J = 6.4 Hz, 1 H, 
ArH), 6.81 (t, J = 7.2 Hz, 1 H, ArH), 6.39 (s, 1 H, OH), 5.05 
(s, 2 H, NH2), 3.40 (s, 3 H, CH3), 1.33 (s, 3 H, CH3); 
13C 
NMR (DMSO-d6, 75 MHz) δ: 178.5, 146.2, 141.7, 133.2, 
129.3, 125.0, 121.8, 109.7, 98.3, 74.6, 33.7, 12.6; HRMS 
(EI) calcd. for C13H14N4O2 (M) 258.1117, found 258.1120. 
3-(5-amino-1,3-dimethyl-1H-pyrazol-4-yl)-4-chloro-3- 
hydroxyindolin-2-one (3eb). Light yellow solid; m.p. 197– 
199°C; IR (KBr) : ν 3454, 3336, 3020, 1724, 1618, 1557, 
1464, 1378 cm−1; 1H NMR (DMSO-d6, 400 MHz) δ: 10.49 
(s, 1H, NH), 7.23 (t, J = 7.6 Hz, 1H, ArH), 6.93 (d, J = 8.0 
Hz, 1H, ArH), 6.80 (d, J = 7.5 Hz, 1H, ArH), 6.47 (s, 1H, 
OH), 5.06 (s, 2H, NH2), 3.41 (s, 3H, CH3), 1.34 (s, 3H, 
CH3); 
13C NMR (DMSO-d6, 100 MHz) δ: 183.1, 152.2, 
149.1, 146.4, 136.5, 136.3, 134.3, 127.9, 113.9, 101.2, 80.6, 
39.0, 17.4; HRMS (EI) calcd. for C13H13ClN4O2 (M) 
292.0727, found 292.0719. 
3-(5-amino-1,3-dimethyl-1H-pyrazol-4-yl)-3-hydroxy-5- 
methylindolin-2-one (3fb). Light yellow solid; m.p. 
160–162°C; IR (KBr) : ν 3375, 3314, 3019, 2810, 1735, 
1613, 1476, 1450, 1388 cm−1; 1H NMR (DMSO-d6, 400 
MHz) δ: 10.50 (s, 1 H, NH), 7.23 (t, J = 7.6 Hz, 1 H, ArH), 
6.93 (d, J = 8.0 Hz, 1 H, ArH), 6.79 (d, J = 7.6 Hz, 1 H, 
ArH), 6.49 (s, 1 H, OH), 5.06 (s, 2 H, NH2), 3.41 (s, 3 H, 
CH3), 2.13 (s, 3 H, CH3), 1.33 (s, 3 H, CH3); 
13C NMR 
(DMSO-d6, 75 MHz) δ: 177.7, 146.7, 143.6, 141.1, 131.8, 
128.9, 122.4, 108.4, 95.9, 75.1, 33.6, 21.2, 12.0; HRMS (EI) 
calcd. for C14H16N4O2 (M) 272.1273, found 272.1270. 
3-(5-amino-1,3-dimethyl-1H-pyrazol-4-yl)-5-fluoro-3- 
hydroxyindolin-2-one (3gb). Light yellow solid; m.p. 193– 
195°C; IR (KBr): ν 3447, 3340, 3011, 2858, 1713, 1613, 
1550, 1489, 1396 cm−1; 1H NMR (DMSO-d6, 400 MHz) δ: 
10.32 (s, 1 H, NH), 7.03−7.08 (m, 2 H, ArH), 6.81−6.84 (m, 
1 H, ArH), 6.56 (s, 1 H, OH), 5.10 (s, 2 H, NH2), 3.42 (s, 3 
H, CH3), 1.37 (s, 3 H, CH3); 
13C NMR (DMSO-d6, 100 
MHz) δ: 183.8, 151.6, 146.8, 143.0, 140.1, 120.8,  117.7, 
115.9, 103.3, 80.1, 39.0, 18.0; HRMS (EI) calcd. for 
C13H13FN4O2 (M) 276.1023, found 276.1028. 
3-(5-amino-3-methyl-1H-pyrazol-4-yl)-5-chloro-3-hydro-  
xyindolin-2-one (3ac). Light yellow solid; m.p. 204–206°C; 
IR (KBr) : ν 3424, 3345, 3297, 2934, 2849, 1707, 1616, 
1473 cm−1; 1H NMR (DMSO-d6, 400 MHz) δ: 11.22 (s, 1 H, 
NH), 10.47 (s, 1 H, NH), 7.35 (s, 1 H, ArH), 7.26 (d, J = 8.0 
Hz, 1 H, ArH), 6.84 (t, J = 8.4 Hz, 1 H, ArH), 6.52 (s, 1 H, 
OH), 4.47 (s, 2 H, NH2), 1.66s (s, 3 H, CH3); 
13C NMR 
(DMSO-d6, 100 MHz) δ: 183.3, 145.4, 140.9, 134.7, 134.2, 
131.2, 130.0, 116.7, 79.6, 78.6, 16.2; HRMS (EI) calcd. for 
C12H11ClN4O2 (M) 278.0571, found 278.0570. 
3-(5-amino-3-methyl-1H-pyrazol-4-yl)-5-bromo-3-hydro- 
xyindolin-2-one (3bc). Light yellow solid; m.p. 220–222°C; 
IR (KBr) : ν 3360, 3277, 3072, 2832, 1712, 1615, 1475 cm−1; 
1H NMR (DMSO-d6, 400 MHz) δ: 11.22 (s, 1 H, NH), 10.49 
(s, 1 H, NH), 7.44 (s, 1 H, ArH), 7.39 (d, J = 8.0 Hz, 1 H, 
ArH), 7.80 (t, J = 8.0 Hz, 1 H, ArH), 6.53 (s, 1 H, OH), 4.55 
(s, 2 H, NH2), 1.63 (s, 3 H, CH3); 
13C NMR (DMSO-d6, 75 
MHz) δ: 177.8, 146.0, 141.2, 140.5, 135.9, 131.8, 127.8, 
113.5, 111.9, 74.2, 10.9; HRMS (EI) calcd. for C12H11BrN4 
O2 (M) 322.0065, found 322.0065. 
3-(5-amino-3-methyl-1H-pyrazol-4-yl)-4-chloro-3-hydro- 
xyindolin-2-one (3ec). Light yellow solid; m.p. 213–215°C; 
IR (KBr) : ν 3424, 3345, 3297, 2934, 2849, 1707, 1616, 
1473 cm−1; 1H NMR (DMSO-d6, 400 MHz) δ: 11.22 (s, 1 H, 
NH), 10.50 (s, 1 H, NH), 7.25 (t, J = 8.0 Hz, 1 H, ArH), 
6.95 (d, J = 8.0 Hz, 1 H, ArH), 6.81 (d, J = 8.0 Hz, 1 H, 
ArH), 6.38 (s, 1 H, OH), 4.50 (s, 2 H, NH2), 1.52 (s, 3 H, 
CH3); 
13C NMR (DMSO-d6, 100 MHz) δ: 177.8, 143.6, 
131.1, 130.9, 128.9, 108.6, 98.0, 75.1, 10.6; HRMS (EI) 
calcd. for C12H11ClN4O2 (M) 278.0571, found 278.0578. 
3-(5-amino-3-methyl-1H-pyrazol-4-yl)-3-hydroxy-5-met
hylindolin-2-one (3fc). Light yellow solid; m.p. 236–238°C; 
IR (KBr) : ν 3432, 3348, 2828, 1707, 1608, 1536, 1492 
cm−1; 1H NMR (DMSO-d6, 400 MHz) δ: 11.16 (s, 1 H, NH), 
10.19 (s, 1 H, NH), 7.11 (s, 1 H, ArH), 7.01 (d, J = 8.0 Hz, 
1 H, ArH), 6.72 (d, J = 8.0 Hz, 1 H, ArH), 6.27 (s, 1 H, OH), 
4.45 (s, 2 H, NH2), 2.23 (s, 3 H, CH3), 1.59 (s, 3 H, CH3); 
13C NMR (DMSO-d6, 75 MHz) δ: 178.5, 138.9, 133.5, 
130.7, 129.3, 125.4, 109.5, 74.4, 20.8, 12.3; HRMS (EI) 
calcd. for C13H14N4O2 (M) 258.1117, found 258.1118. 
3-(5-amino-3-methyl-1H-pyrazol-4-yl)-5-fluoro-3-hydro-
xyindolin-2-one (3gc). Light yellow solid; m.p. 200–202°C; 
IR (KBr) : ν 3419, 3339, 3291, 2928, 2845, 1703, 1614, 
1470 cm−1; 1H NMR (DMSO-d6, 400 MHz) δ: 11.12 (s, 1 H, 
NH), 10.32 (s, 1 H, NH), 7.03−7.08 (m, 2 H, ArH), 6.82 (dd, 
J = 4.0 Hz, 4.0 Hz, 1 H, ArH), 6.56 (s, 1 H, OH), 5.10 (s, 2 
H, NH2), 1.37 (s, 3 H, CH3); 
13C NMR (DMSO-d6, 75 MHz) 
δ: 178.5, 159.8, 156.7, 146.3, 141.5, 137.8, 135.1, 135.0, 
115.7, 112.6, 110.7, 97.9, 74.8, 12.6; HRMS (EI) calcd. for 
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C12H11FN4O2 (M) 262.0866, found 262.0865. 
2  Results and discussion 
Our initial attempt was focused on the feasibility of the 
model reaction of isatin 1b with 5-aminopyrazole 2a under 
catalyst-free condition (Scheme 1). It was fortunately found 
that the reaction could be performed well in acetic acid at 
100°C to give the desired product in 80% yield (entry 1, 
Table 1). A comparable yield was obtained when the reac-
tion was carried out in ethyl acetate (entry 2, Table 1). To 
our surprise, an improved yield of 91% was afforded when 
the reaction was performed in refluxing water (entry 3, Ta-
ble 1). Employment of ethanol as solvent exhibited pre-
dicTable decrease of product yield, and the combination of 
water and ethanol was also successful to produce the satis-
factory result (entries 4–5, Table 1). In view of the fact that 
water was a greener solvent than others and the reaction 
time was shortest with the use of water as solvent, so the 
optimal reaction conditions were defined as catalyst-free 
and refluxing water. 
With the success of above optimization, next the sub-
strate scope was examined (Scheme 2). As is seen from 
Table 2, isatins bearing substituents such as 5-Cl, 5-Br, 6-Br, 
4-Cl, 5-Me, 5-F, 5-OMe could work well in the reactions 
with 2a to produce the desired products in 88%−95% yield 
(entries 1–3, 5–8, Table 2). The generality of substrate 2 
was also surveyed. Under the established conditions, intro-
duction of 2b into the reaction system led to a viscous and 
messy mixture and no isolable product could be obtained, 
which may be due to the lower melting point of 2b. Inter-
estingly, when the reaction temperature was decreased to 
60 °C, we were gratifying to find that all the reactions pro-
ceeded smoothly, giving rise to the final products in good to 
excellent yields after prolonged reaction times (entries 9–15, 
Table 2). In addition, 5-amino-3-methylpyrazole 2c was 
also proven to be a suitable candidate for the transformation 
(entries 16–20, Table 2), showing comparable performance 
when the reaction was manipulated under the same condi-
tions employed for the substrate 2b.  
3  Conclusions 
In summary, we have demonstrated a green and efficient 
approach for the alkylation of aminopyrazole in water under 






















Table 1  Optimization of reaction conditions a)  
Entry Solvent Temperature (°C) Time (h) Yield (%)b) 
1 AcOH 100 12 80 
2 EtOAc  80 12 83 
3 H2O 100  4 91 
4 EtOH  80 12 85 
5 H2O/EtOH (6:1 v/v)  80 12 90 


















R1 = 5-Cl, 1a; 5-Br, 1b
6-Br, 1c; H, 1d
4-Cl, 1e; 5-Me, 1f
5-F, 1g; 5-OMe, 1h






2948 Yang J M, et al.   Chin Sci Bull   August (2013) Vol.58 No.24 
Table 2  Substrate scope study a) 


































































































































































































































3gc 18 90 
a) Conditions: 1 (0.5 mmol), 2 (0.5 mmol), and H2O (3 mL) under refluxing; b) isolated yield. 
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under optimized conditions to furnish the corresponding 
products bearing both oxindole and pyrazole moieties in 
good to excellent yields. The mild reaction conditions, sim-
ple manipulation, and the green feature of process make the 
present method attractive for organic synthesis. In addition, 
in view of the presence of multi-functionality in the ob-
tained products, these compounds were potentially useful as 
promising intermediates for many organic transformations. 
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